Treatment of bladder cancer-cell lines with romidepsin resulted in a dose- and time-dependent growth inhibition, cell-cycle arrest, elevated p21WAF1 levels via a p53 independent pathway and apoptosis induction [202]. Here, TP53 is linked to urinary bladder carcinoma.